Neurotrophism, mitogenesis, and nerve regeneration as models for neuropeptide mediation. Introduction to Part VI.
Section on Developmental and Molecular Pharmacology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
D E
DE
Brenneman
D000818:Animals; D002455:Cell Division; D006801:Humans; D008959:Models, Neurological; D009416:Nerve Regeneration; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D009479:Neuropeptides / Q000494:pharmacology / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000502:physiology; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D018013:Receptors, Neuropeptide / Q000096:biosynthesis / Q000502:physiology; D014660:Vasoactive Intestinal Peptide / Q000502:physiology
C495401:ADCYAP1 protein, human; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D018013:Receptors, Neuropeptide; D014660:Vasoactive Intestinal Peptide